RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/35137
https://w3id.org/ripe/ripe-kg/retraction-notice/35137
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA1195AD8EF5C09D44 |
prov:used |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prism:doi |
10.1093/ecco-jcc/jjab227 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prism:publicationDate |
2022-01-24 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prism:publicationName |
Journal of Crohn's and Colitis |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
dcterms:publisher |
ripekg:publisher/RIPEP071DE88059C4E4B3Oxford Academic |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
dcterms:title |
Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1016%2Fj.crohns.2014.01.010 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
owl:Thing |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
owl:sameAs |
https://semopenalex.org/work/W4206952268 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA1195AD8EF5C09D44 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA1195AD8EF5C09D44 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripe:concerns |
ripekg:author/RIPEAUAEF17FD69B8E6050Edward Mills |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripe:concerns |
ripekg:work/10.1016%2Fj.crohns.2014.01.010 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripe:rationale |
Civil Proceedings;Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Legal Reasons and/or Threats |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
ripe:retractionWatchRecordId |
35137 |
ripekg:retraction-notice/35137Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1195AD8EF5C09D44-inspectai-1-3 |